“The pause in AstraZeneca’s COVID-19 vaccine trial shows it is a ‘well-run’ trial,” World Health Organisation (WHO) said in a statement on Tuesday.
The WHO, further, said that the pause showed that they have looked at safety in ‘an appropriate manner’.
developing story ….